Horus
Fiber Optic 300/500/600
Laser Probes are designed for use in vitreoretinal surgery to perform endo-ocular laser photocoagulation treatments at wavelengths from 500nm to 900nm. Laser fibers are fused at the tip of the probe to reduce ghosting and allow working even closer to the tissue.
Designed for use in vitreoretinal surgery to perform endo-ocular laser photocoagulation treatments
Wavelengths from 500nm to 900nm
Continuously adjustable articulation designed to offer greater surgical reach than conventional laser probes
Detailed specifications
Standard Laser Probe
- Precision centered fiber
- Plastic grip with enhanced tactile feel
Illuminated Laser Probe
- Combines lighting and laser functions in a one-hand grip.
- Allows “free hand” to perform other surgical maneuvers.
- Laser photocoagulation therapy
- Built-in illumination to aid surgical imaging
- Continuously adjustable articulation designed to offer greater surgical reach than conventional laser probes
Laser Probes are designed for use in vitreoretinal surgery to perform endo-ocular laser photocoagulation treatments at wavelengths from 500nm to 900nm. Laser fibers are fused at the tip of the probe to reduce ghosting and allow working even closer to the tissue.
Standard Laser Probe
- Precision centered fiber
- Plastic grip with enhanced tactile feel
Illuminated Laser Probe
- Combines lighting and laser functions in a one-hand grip.
- Allows “free hand” to perform other surgical maneuvers.
- Laser photocoagulation therapy
- Built-in illumination to aid surgical imaging
- Continuously adjustable articulation designed to offer greater surgical reach than conventional laser probes
ADVANTAGES
- A wide variety of laser probes expand your surgical options.
- Different connectors to fit most commercially available laser source models.
- Panretinal photocoagulation in proliferative diseases such as proliferative diabetic retinopathy and venous occlusive diseases
- Focal or grid photocoagulation for macular edema from diabetes or branch vessel occlusion
- Treatment of threshold of prematurity and high-risk pretreshold retinopathy
- Closure of retinal microvascular abnormalities such as microaneurysms, telangiectasia, and perivascular leakage
- Focal ablation of the extrafoveal choroidal neovascular membrane
- Focal treatment of pigment abnormalities such as avoidance of central serous chorioretinopathy.
- Treatment of ocular tumors
- Formation of chorioretinal adhesions surrounding retinal breaks and detached areas.
| Order Number | Moldels | Øcore (µm) | Øouter (µm) | NA | Lenght (m) | Øışın (µm) | NA | Connector |
| DCR1005 | Radial Fiber | 300 | 360 | 0.22 | 3 | ≤500 | ≤0.22 | SMA 905 |
| DCR1006 | Radial Slim Fiber | 500 | 360 | 0.22 | 3 | ≤400 | ≤0.22 | SMA 905 |
| DCR1007 | Radial 2 ring Fiber | 500 | 1300 | 0.26/0.37 | 2.6 | ≤500 | ≤0.26 for >50 W ≤0.36 for ≤50W |
SMA 905 |
| DCR1008 | Radial slim 2 ring Fiber | 600 | 1300 | 0.26/0.37 | 2.6 | ≤400 | ≤0.26 for >50 W ≤0.36 for ≤50W |
SMA 905 |
| DCR1009 | Radial slim 2 ring Fiber | 600 | 950 | 0.37 | 3 | ≤401 | ≤0.37 | SMA 906 |
| DCR1010 | Radial slim 2 ring Fiber | 600 | 950 | 0.37 | 3 | ≤402 | ≤0.37 | SMA 907 |
